Type-specific cell line models for type-specific ovarian cancer researchOvarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypesThe Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityA genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancersData for identification of GPI-anchored peptides and ω-sites in cancer cell linesLectin array and glycogene expression analyses of ovarian cancer cell line A2780 and its cisplatin-resistant derivate cell line A2780-cp.Characterization of Human Cancer Cell Lines by Reverse-phase Protein ArraysBRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation.CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential.Essential gene profiles in breast, pancreatic, and ovarian cancer cells.Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies.Genomic complexity and AKT dependence in serous ovarian cancer.Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation.DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contaminationEvaluating cell lines as tumour models by comparison of genomic profiles.A landscape of pharmacogenomic interactions in cancer.Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status.A comprehensive transcriptional portrait of human cancer cell lines.Evidence that both genetic instability and selection contribute to the accumulation of chromosome alterations in cancer.Characterization of ovarian cancer cell lines as in vivo models for preclinical studies.Identification of glycosylphosphatidylinositol-anchored proteins and ω-sites using TiO2-based affinity purification followed by hydrogen fluoride treatment.Comparative proteomic analysis of paclitaxel sensitive A2780 epithelial ovarian cancer cell line and its resistant counterpart A2780TC1 by 2D-DIGE: the role of ERp57.Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines.Radiation survival parameters of antineoplastic drug-sensitive and -resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine.
P4510
Q54582664-3018CD11-BBAD-4F45-A011-4226D74BADDEQ54606563-8632E6D1-C1E6-4A4D-8618-A8CB7EC7A37EQ54606564-6BA0B333-D1BA-41B8-9295-3BBE9D51ABEAQ54606565-2FCC3EA2-E34B-4143-9F81-8303A0F8F953Q54606579-54A5FDDA-9BC3-4B52-A555-D0479F2437C7Q54606582-60FFFC4E-49B5-418C-8A4B-DB2A785458E2Q54606583-3E663CD0-1030-4A86-8866-A408CCA591F2Q54606586-5CDC70F8-2229-42C0-ADA9-AC1CA0139684Q54606587-FC5333A1-DBCB-409F-9443-A13E92662427Q54606588-5B14457A-9EDB-4FFE-A25F-DD1883779231Q54606592-1C6953B4-64D9-484A-A561-8CDE32A8B19EQ54606593-F15594F3-B618-42E7-93DA-6E6006074AD2Q54606596-7DB03751-D35E-4F33-99B6-1B2421BC12D3Q54606598-8F5C1FC9-542B-4667-8B15-F0516DC76660Q54606601-038BB2E7-94A6-4DBA-8681-54E9D9BC3E36Q54606602-54967D7D-901D-4744-BEB8-88333CCF189FQ54606604-5E0D6B3C-225A-4B7F-8C27-D56FDFBFA6BFQ54606605-261E602E-A8F9-4FF8-B69D-5B6C33B13F1EQ54606607-F32FB9CC-0C8D-4FC6-BB7B-A7325E3A1EA3Q54606608-5D0AAD3C-4054-45B6-9CFC-6FEEBD24DF5AQ54606611-D6D59B55-912B-4DA9-A4E6-B884E49F084DQ54606613-CEE4BEBF-6E9C-44D3-BB61-CA47126C3E2BQ54606614-92C3160B-5B7F-4433-BBD5-FDFE7E06EDF8Q93311561-97CD14C6-C062-4545-97FD-545923BEDC69Q93311635-AC336F01-2299-4D93-8E0F-389CE2D8B56FQ93311647-B418E60F-47FB-4D64-9829-F684B3DE5D1E
P3432
Q28536689-695D190C-4F4C-4F9A-9134-C130BBFA039DQ28543021-7836E427-C9CE-4D6F-ABEC-E028A1A06567Q29547693-4CB9D359-A09E-40C7-8916-F1555D7C7891Q30434796-BF3D2C42-7778-4273-BEC5-39DC0025C52AQ31089881-24780E55-C205-4B5C-8000-7BD9F45EA2A2Q33722717-21FAA557-1C29-4199-B248-40FAA0DD976DQ33882864-405617AE-5F03-485C-B666-D305FB47BBCEQ33930051-1844B094-D895-4726-B75A-F905EB3CCFDEQ34134934-0B8D8919-9335-4FEB-966C-D3493A72E21DQ34268870-7F8E3476-CB27-4BEA-96A4-333CAA37E13EQ35609041-BB5B70D8-65DC-4F30-8895-4AF28906A408Q35743316-0FEA1907-85F2-4D93-B7B2-BD40F7FD1DF7Q35818950-E9F7742E-2B84-40CB-A223-FD27E315625FQ36204976-502F8A21-C74A-426D-B556-44215EA729A1Q37025950-3AC05C0E-F9E9-4F87-911A-7BC9FBE610D5Q37140236-CA15C5C1-E247-40EC-AAA8-26D849CA5B21Q37223322-E85E05EF-4890-49D4-811C-6287B51EFFCCQ37854720-FE87042F-5DD4-448A-AA20-0F9446FE0208Q38475420-780546C3-6939-4193-90D4-1FC64EA86C41Q38767850-576F0590-CC1B-405C-AA9D-B988B674CE20Q38786753-E61912C5-F601-401B-AEF8-454E258752EEQ39806942-F5E0AE9B-2281-4695-93BB-D1ECFC291DDAQ42814149-76BDB668-4636-4122-8AD6-73B0554F9801Q52826671-2FDC5F39-5295-460F-8C1A-DDC844729CD7
P4510
description
Zelllinie
@de
ceall-líne
@ga
cell line
@en
cellijn van een Homo sapiens
@nl
lignée cellulaire
@fr
name
A2780
@de
A2780
@en
A2780
@fr
A2780
@ga
A2780
@nl
A2780
@zh
type
label
A2780
@de
A2780
@en
A2780
@fr
A2780
@ga
A2780
@nl
A2780
@zh
altLabel
2780
@en
A-2780
@en
A2780S
@en
prefLabel
A2780
@de
A2780
@en
A2780
@fr
A2780
@ga
A2780
@nl
A2780
@zh